372 results on '"McAlpine, Jessica N."'
Search Results
2. VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology
3. Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis
4. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study
5. p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?
6. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
7. Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
8. Single-cell genomic variation induced by mutational processes in cancer
9. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
10. Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
11. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
12. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach
13. BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
14. Endometrial cancer
15. Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol
16. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
17. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
18. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome
19. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
20. The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile.
21. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique
22. Endometrial Carcinoma Molecular Subtype Correlates With the Presence of Lymph Node Metastases
23. Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
24. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns
25. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status
26. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
27. Therapeutic options for mucinous ovarian carcinoma
28. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
29. From biobank and data silos into a data commons: convergence to support translational medicine
30. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
31. Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
32. Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer
33. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma
34. FIGO 2023 endometrial cancer staging: too much, too soon?
35. Improving response to progestin treatment of low-grade endometrial cancer
36. Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.
37. Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers
38. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma
39. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
40. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
41. Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
42. Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
43. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada
44. The molecular origin and taxonomy of mucinous ovarian carcinoma
45. Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
46. Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
47. Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study
48. Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factors
49. Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
50. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.